MERCK KGAA O.N./ DE0006599905 /
2024-03-28 7:13:23 PM | Chg. +4.6500 | Volume | Bid7:54:06 PM | Ask7:54:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
162.9000EUR | +2.94% | 690 Turnover: 112,689.2500 |
-Bid Size: - | -Ask Size: - | 21.05 bill.EUR | 1.35% | 25.10 |
GlobeNewswire
03-28
Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA